EGFR and central nervous system cancer: Recently, their finding has been expanded with a role for the EGFR-Ras-MAPK signaling pathway by upregulation of COP9 signalosome complex subunit six (CSN6) and subsequent stabilization of PD-L1 in gliomas (52).